Navigation Links
Insmed to Host 2012 Second Quarter Earnings Conference Call
Date:7/24/2012

MONMOUTH JUNCTION, N.J., July 24, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the lung, will host a conference call on Tuesday, August 7th, 2012, at 8:30 AM ET, to discuss its financial results for the second quarter of 2012.  Insmed intends to issue its quarterly financial results press release before the market opens on August 7th.

To participate in the live conference call, please dial 800-299-7089 (U.S. callers) or 617-801-9714 (international), and provide passcode 17092264.  A live webcast of the call will also be available at http://www.media-server.com/m/p/uk852bf4.  Please allow extra time prior to the webcast to register, download and install any necessary audio software.

The webcast will be archived for 30 days, and a telephone replay of the call will be available for seven days, beginning at 10:30 AM ET on August 7th, at 888-286-8010 (U.S. callers) or 617-801-6888 (international), using passcode 11016101.

About Insmed

Insmed Incorporated is a biopharmaceutical company focused on the development of innovative inhaled pharmaceuticals for the site-specific treatment of serious lung diseases.  Insmed's primary focus is on the development of inhaled antibiotic therapy delivered via proprietary advanced liposomal pulmonary technology in areas of high unmet need.  For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to our financial position, our estimates regarding our capital requirements and ou
'/>"/>

SOURCE Insmed Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Insmed To Present At JMP Securities 7th Annual Healthcare Conference
2. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease
3. Insmed Announces First Quarter 2012 Financial Results
4. Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections
5. Insmed to Host 2012 First Quarter Earnings Conference Call
6. MAP Pharmaceuticals Reports Second Quarter of 2012 Financial Results
7. Lexicon to Provide Second Quarter 2012 Financial Results
8. Onyx Pharmaceuticals To Report Second Quarter 2012 Financial Results After Market On August 1, 2012
9. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
10. InterMune Reports Second Quarter 2012 Financial Results and Business Highlights
11. Webcast Alert: Isis Pharmaceuticals Second Quarter 2012 Financial Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... KING OF PRUSSIA, Pa. , May 22, ... awarded CSL Behring its 2015 Corporate Leadership Award ... advancing science and improving the care of the bleeding disorders ... CEO and Managing Director, CSL Limited, during the NHF Annual ... on May 21. "The National Hemophilia Foundation is ...
(Date:5/22/2015)... According to a new market ... Instruments, Services), by Test Type (Indirect, Enzyme-based, Reactive Oxygen ... End Users - Global Forecast to 2020", published by ... reach $736.85 Million by 2020 from $452.36 Million in ... Browse 71 market data Tables and 90 Figures ...
(Date:5/22/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/3rthk2/latest ) ... Regulations on Pharmaceutical International Multi-Center Clinical Trials in ... This is first time in history, Chinese pharmaceutical ... clinical trials of drugs in China ... on March 1, 2015. The guidance provides an ...
Breaking Medicine Technology:National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 42015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... achieve undetectable HCV RNA levels following 4 weeks of, treatment with R7128 ... ... - Conference Call Scheduled for 4:00PM ET Today ... announces the preliminary results of a 4-week Phase 1,clinical trial to evaluate ...
... Calif., Jan. 7 Jazz,Pharmaceuticals, Inc. (Nasdaq: ... drug designation from the U.S. Food and Drug ... treatment of recurrent acute,repetitive seizures. In December 2007, ... II clinical trial of JZP-8., JZP-8 is ...
Cached Medicine Technology:Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C 2Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C 3Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C 4Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C 5Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C 6Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate 2Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate 3
(Date:5/22/2015)... River Valley Health Partners (RVHP) Board ... system’s Chief Financial Officer (CFO), will be leaving the ... the company CFO since 2011. , The Board of ... health system as CFO. Wesley will oversee the health ... Board of Trustees conducts a formal search for a ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Hands On ... June 17, 2015, the Annual One Day Sale ... 2007, Hands On HCMT offers drastically reduced certificates one day ... estheticians have enough sessions, through what used to be the ... wonderful for the community as well. This once a year ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Memorial Day weekend ... Amica Insurance is offering some tips to help promote ... Council, there will be 383 traffic fatalities this Memorial Day ... the National Highway Traffic Safety Association: , ... the vehicle is wearing a seatbelt, whether they’re driving or ...
(Date:5/22/2015)... PA (PRWEB) May 22, 2015 According to ... a hub for drug related death, totaling almost 2,500 confirmed ... as reported by state officials, totals 2,489 deaths stemming from ... work out, Pennsylvania loses seven people every day to fatal ... has been singled out as one of the most rife ...
(Date:5/22/2015)... A Phase 3 French study, which ... Clinical Oncology (ASCO)’s annual meeting at the end ... patients who received bevacizumab in addition to the ... Genentech, Inc.) is an antibody that blocks angiogenesis ... used to treat many other cancers, including lung ...
Breaking Medicine News(10 mins):Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2
... over sexual behaviors strongly influences Latina womens decisions of ... the University of Chicago Medical Center in the November ... sense of personal control over sexual behaviors appeared to ... Latina womens own beliefs regarding timing of first sexual ...
... at LSU Health Sciences Center New Orleans has been ... the William J. Gies Award for Outstanding Innovation. The ... a black-tie celebration on March 29, 2008 in conjunction ... Session at the Hilton Anatole in Dallas, Texas. Named ...
... release there are hypnotic suggestions about why you should cover this ... to pick out the suggestions? Or would they work without you ... the news, you came to the realization that you absolutely, must ... you read on , In his fifth and new self-published book ...
... 16 The following is a,statement by Reverend Carlton ... Reproductive Choice:, "On the 35th anniversary of Roe ... its commitment that abortion will be safe, legal, and ... Court,s Gonzales v. Carhart,opinion and the ,fetal personhood, initiatives ...
... Jan. 16 With the ringing in of a ... mark the,company,s successes and will be the foundation of ... customer base 600% in 2007, Vendormate now serves,more than ... across the U.S., "Vendormate is the ,must have, ...
... Allowing Pharmacies to Negotiate Collectively Would,Increase Costs by ... Jan. 16 Despite pharmacy benefit,managers, (PBMs) claims ... negotiate with PBMs, would increase costs to,Medicare D ... Congressional,Budget Office (CBO) rejected this bogus number., ...
Cached Medicine News:Health News:Sense of personal control influences Latinas' decisions about sexual debut 2Health News:LSUHSC dental school to be awarded top national honor 2Health News:Hypnotist ready to kick cigarette butt 2Health News:Statement of the Reverend Carlton W. Veazey, President and CEO of the Religious Coalition for Reproductive Choice, on the 35th Anniversary of Roe v. Wade 2Health News:Vendormate Storms into 2008 with Major Milestones for Hospital Vendor Compliance 2Health News:Congressional Budget Office Analysis of HR971 Rejects Pharmacy Benefit Managers' Bogus Claim Bill Would Cost $29 Billion Over 5 Years 2
... TST 40 tissue stainer is an "assembly-line ... in histology and cytology laboratories. Programmable continuous ... stains big quantities of slides in short ... in combination with a continuous working principle ...
DS 100, double side an economical, easy-to-use instrument for the automatic staining in histology and cytology....
Cholesterol, Total. An automated analyzer test kits....
For the quantitative determination of total cholesterol in serum....
Medicine Products: